GCT(GCT)
GCT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.53B | $1.64B |
| Low | $1.52B | $1.63B |
| High | $1.54B | $1.65B |
| EBITDA Avg | $181M | $194M |
| Low | $180M | $193M |
| High | $182M | $196M |
| EBIT Avg | $174M | $187M |
| Low | $173M | $185M |
| High | $175M | $188M |
| Net Income Avg | $161M | $179M |
| Low | $160M | $177M |
| High | $163M | $180M |
| EPS Avg | $4.21 | $4.67 |
| Low | $4.18 | $4.63 |
| High | $4.26 | $4.71 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $376M | $401M | $387M | $412M | $408M | $442M |
| Low | $372M | $392M | $383M | $407M | $403M | $437M |
| High | $381M | $411M | $391M | $416M | $412M | $447M |
| EBITDA Avg | $45M | $47M | $46M | $49M | $48M | $52M |
| Low | $44M | $46M | $45M | $48M | $48M | $52M |
| High | $45M | $49M | $46M | $49M | $49M | $53M |
| EBIT Avg | $43M | $46M | $44M | $47M | $46M | $50M |
| Low | $42M | $45M | $43M | $46M | $46M | $50M |
| High | $43M | $47M | $44M | $47M | $47M | $51M |
| Net Income Avg | $38M | $44M | $42M | $41M | $48M | $49M |
| Low | $37M | $44M | $41M | $40M | $47M | $48M |
| High | $39M | $45M | $42M | $41M | $49M | $50M |
| EPS Avg | $1.04 | $1.22 | $1.14 | $1.11 | $1.31 | $1.34 |
| Low | $1.02 | $1.20 | $1.12 | $1.09 | $1.29 | $1.32 |
| High | $1.05 | $1.23 | $1.16 | $1.13 | $1.33 | $1.36 |
| Analysts (Rev / EPS) | 2 / 1 | 3 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |